New Industries released its 2026 interim report, with net profit attributable to the parent company of 868 million yuan, up 12.53% from the same period last year. Total operating revenue was 2.42 billion yuan, up 10.78% year on year. Net cash inflow from operating activities was 901 million yuan, up 95.29% year on year. The company's latest gross margin was 70.88%, an increase of 2.45 percentage points from the same period last year. Diluted earnings per share were 1.11 yuan, up 12.67% year on year.
Shenzhen New Industries BiomedicalReports higher net profit and revenue growth.